These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31503512)

  • 21. L-Cell Differentiation Is Induced by Bile Acids Through GPBAR1 and Paracrine GLP-1 and Serotonin Signaling.
    Lund ML; Sorrentino G; Egerod KL; Kroone C; Mortensen B; Knop FK; Reimann F; Gribble FM; Drucker DJ; de Koning EJP; Schoonjans K; Bäckhed F; Schwartz TW; Petersen N
    Diabetes; 2020 Apr; 69(4):614-623. PubMed ID: 32041793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice.
    Hunt JE; Billeschou A; Windeløv JA; Hartmann B; Ullmer C; Holst JJ; Kissow H
    Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G980-G987. PubMed ID: 32308039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
    Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of Endogenous (Male) Rodent GLP-1 Secretion and Human Islet Insulin Secretion by Antagonism of Somatostatin Receptor 5.
    Farb TB; Adeva M; Beauchamp TJ; Cabrera O; Coates DA; Meredith TD; Droz BA; Efanov A; Ficorilli JV; Gackenheimer SL; Martinez-Grau MA; Molero V; Ruano G; Statnick MA; Suter TM; Syed SK; Toledo MA; Willard FS; Zhou X; Bokvist KB; Barrett DG
    Endocrinology; 2017 Nov; 158(11):3859-3873. PubMed ID: 28938487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Farnesoid X Receptor (FXR) Interacts with Camp Response Element Binding Protein (CREB) to Modulate Glucagon-Like Peptide-1 (7-36) Amide (GLP-1) Secretion by Intestinal L Cell.
    Li P; Zhu L; Yang X; Li W; Sun X; Yi B; Zhu S
    Cell Physiol Biochem; 2018; 47(4):1442-1452. PubMed ID: 29940597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endocrine disrupting potential of monosodium glutamate (MSG) on secretion of the glucagon-like peptide-1 (GLP-1) gut hormone and GLP-1 receptor interaction.
    Shannon M; Green B; Willars G; Wilson J; Matthews N; Lamb J; Gillespie A; Connolly L
    Toxicol Lett; 2017 Jan; 265():97-105. PubMed ID: 27890806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel extrapancreatic effects of incretin.
    Yamada Y; Tsukiyama K; Sato T; Shimizu T; Fujita H; Narita T
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):76-9. PubMed ID: 27186360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum.
    Hansen L; Hartmann B; Bisgaard T; Mineo H; Jørgensen PN; Holst JJ
    Am J Physiol Endocrinol Metab; 2000 Jun; 278(6):E1010-8. PubMed ID: 10827002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L- and D-cells in mice.
    Ye DZ; Kaestner KH
    Gastroenterology; 2009 Dec; 137(6):2052-62. PubMed ID: 19737569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Farnesoid X receptor interacts with cAMP response element binding protein to modulate glucagon-like peptide-1 (7-36) amide secretion by intestinal L cell.
    Li P; Zhu L; Yang X; Li W; Sun X; Yi B; Zhu S
    J Cell Physiol; 2019 Aug; 234(8):12839-12846. PubMed ID: 30536761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.
    Damholt AB; Buchan AM; Kofod H
    Endocrinology; 1998 Apr; 139(4):2085-91. PubMed ID: 9528997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neprilysin inhibition in mouse islets enhances insulin secretion in a GLP-1 receptor dependent manner.
    Esser N; Barrow BM; Choung E; Shen NJ; Zraika S
    Islets; 2018; 10(5):175-180. PubMed ID: 30142012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-specific resetting of mouse islet cellular clocks by glucagon, glucagon-like peptide 1 and somatostatin.
    Petrenko V; Dibner C
    Acta Physiol (Oxf); 2018 Apr; 222(4):e13021. PubMed ID: 29271578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Human Relevant Defined Mixture of Persistent Organic Pollutants (POPs) Affects In Vitro Secretion of Glucagon-Like Peptide 1 (GLP-1), but Does Not Affect Translocation of Its Receptor.
    Shannon M; Xie Y; Verhaegen S; Wilson J; Berntsen HF; Zimmer KE; Ropstad E; Green BD; Connolly L
    Toxicol Sci; 2019 Dec; 172(2):359-367. PubMed ID: 31432086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
    Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
    Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport.
    Lee J; Koehler J; Yusta B; Bahrami J; Matthews D; Rafii M; Pencharz PB; Drucker DJ
    Mol Metab; 2017 Mar; 6(3):245-255. PubMed ID: 28271031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue.
    Sangle GV; Lauffer LM; Grieco A; Trivedi S; Iakoubov R; Brubaker PL
    Endocrinology; 2012 Feb; 153(2):564-73. PubMed ID: 22186413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic administration of voglibose, an alpha-glucosidase inhibitor, increases active glucagon-like peptide-1 levels by increasing its secretion and decreasing dipeptidyl peptidase-4 activity in ob/ob mice.
    Moritoh Y; Takeuchi K; Hazama M
    J Pharmacol Exp Ther; 2009 May; 329(2):669-76. PubMed ID: 19208898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene.
    Cordier-Bussat M; Bernard C; Levenez F; Klages N; Laser-Ritz B; Philippe J; Chayvialle JA; Cuber JC
    Diabetes; 1998 Jul; 47(7):1038-45. PubMed ID: 9648826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity.
    Yaribeygi H; Sathyapalan T; Sahebkar A
    Life Sci; 2019 Oct; 234():116776. PubMed ID: 31425698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.